Mao Zhang

7PUBLICATIONS
4CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 01, 2024
SOCS5-RBMX stimulates SREBP1-mediated lipogenesis to promote metastasis in steatotic HCC with HBV-related cirrhosis.

Youpeng Wang, Ziyin Zhao, Tingting Guo

|Nov 02, 2022
SOCS5 knockdown suppresses metastasis of hepatocellular carcinoma by ameliorating HIF-1α-dependent mitochondrial damage.

Dingan Luo, Youpeng Wang, Mao Zhang

|Aug 31, 2020
Predictive value of preoperative and postoperative peripheral lymphocyte difference in hepatitis B virus-related hepatocellular cancer patients: Based on the analysis of dynamic nomogram.

Dingan Luo, Haoran Li, Heng Yu

|Jan 08, 2020
High Inflammatory Factor Grading Predicts Poor Disease-Free Survival in AJCC Stage I-II Hepatocellular Carcinoma Patients After R0 Resection.

Mao Zhang, Mei-Sze Chua, Jie Hu

|Dec 20, 2019
miR-449a Is Related to Short-Term Recurrence of Hepatocellular Carcinoma and Inhibits Migration and Invasion by Targeting Notch1.

Bing Han, Jiawei Huang, Zhenjie Yang

|Oct 24, 2019
Correction: SOCS5 inhibition induces autophagy to impair metastasis in hepatocellular carcinoma cells via the PI3K/Akt/mTOR pathway.

Mao Zhang, Shihai Liu, Mei-Sze Chua

Pageof 2

Frequent Collaborators

2 joint publications

Dingan Luo

1 joint publications

Jiawei Huang

1 joint publications

Mao Zhang

1 joint publications

Mei-Sze Chua